LexDanaLexDanabeta
Inventor

Andrew T. Lister

Inventor
London, GB

Overview

2→
Patents
2018–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms33%
G01NInvestigating or analysing materials by determining their chemical or physical properties33%
PatentTitleYear
11,028,444Survival predictor for diffuse large B cell lymphoma20219,970,059Survival predictor for diffuse large B cell lymphoma2018

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2018–2021Patents assigned to BRITISH COLUMBIA CANCER AGENCY BRANCH (2)· patent assignee history
2018–2021Patents assigned to HOSPITAL CLINIC BARCELONA (2)· patent assignee history
2018–2021Patents assigned to JULIUS MAXIMILIANS UNIV OF WUERZBURG (2)· patent assignee history
2018–2021Patents assigned to OSLO UNIV HOSPITAL HF (2)· patent assignee history
2018–2021Patents assigned to UNIV ARIZONA (2)· patent assignee history
2018–2021Based in London, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRITISH COLUMBIA CANCER AGENCY BRANCH22018–2021
HOSPITAL CLINIC BARCELONA22018–2021
JULIUS MAXIMILIANS UNIV OF WUERZBURG22018–2021
OSLO UNIV HOSPITAL HF22018–2021
UNIV ARIZONA22018–2021
Locations
LocationPatentsSpan
London, GB22018–2021